[1]
Sayyid, R.K. et al. 2017. What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?. Canadian Urological Association Journal. 11, 3-4 (Apr. 2017), 118–22. DOI:https://doi.org/10.5489/cuaj.4182.